Neoleukin Therapeutics Inc (NLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLTX | AMGN | VRTX | BMY | GILD |
| Company | Neoleukin Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 13.80 | 273.44 | 429.25 | 57.14 | 93.03 |
| High | 14.36 | 278.00 | 442.89 | 59.25 | 93.29 |
| Low | 13.68 | 272.32 | 424.54 | 57.02 | 92.21 |
| Last | 13.96 | 277.88 | 439.73 | 59.14 | 92.92 |
| Change | +0.20 | +4.44 | +11.73 | +2.05 | -0.12 |
| % Change | +1.45% | +1.62% | +2.74% | +3.59% | -0.13% |
| Volume | 28,275 | 2,496,000 | 1,658,300 | 14,504,300 | 4,086,100 |
| 20-Day Average Volume | 33,865 | 2,879,385 | 1,510,875 | 8,696,680 | 5,815,840 |
| Previous Close | 13.76 | 273.44 | 428.00 | 57.09 | 93.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.45 | 265.79 | 413.21 | 56.82 | 92.01 |
| 20-Day Raw Stochastic | 62.00% | 99.43% | 93.92% | 97.52% | 72.74% |
| 20-Day Relative Strength | 50.56% | 53.68% | 53.17% | 60.40% | 54.96% |
| Weighted Alpha | +35.60 | -12.38 | -0.98 | +26.34 | +24.63 |
| Today's Opinion | 72% Sell | 56% Sell | 72% Sell | 80% Buy | 96% Buy |
| Previous Opinion | 96% Sell | 80% Sell | 72% Sell | 56% Buy | 80% Buy |
| Last Month's Opinion | 88% Sell | 88% Sell | 56% Sell | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.29% since 12/11/23 | +3.32% since 01/15/25 | +3.65% since 01/15/25 | +5.78% since 01/15/25 | +0.58% since 01/15/25 |
| Low | 3.25 on 12/12/23 | 267.15 on 01/16/25 | 415.15 on 01/16/25 | 55.08 on 01/16/25 | 90.82 on 01/16/25 |
| High | 3.64 on 12/15/23 | 278.00 on 01/23/25 | 442.89 on 01/23/25 | 59.25 on 01/23/25 | 93.90 on 01/21/25 |
| 1-Month | |||||
| %Chg | +4.18% since 11/17/23 | +5.26% since 12/23/24 | +8.50% since 12/23/24 | +2.71% since 12/23/24 | -0.51% since 12/23/24 |
| Low | 3.18 on 11/22/23 | 257.05 on 01/06/25 | 397.24 on 01/13/25 | 54.81 on 01/13/25 | 88.57 on 01/10/25 |
| High | 3.68 on 11/30/23 | 278.00 on 01/23/25 | 442.89 on 01/23/25 | 59.25 on 01/23/25 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | -9.35% since 09/18/23 | -11.76% since 10/23/24 | -6.45% since 10/23/24 | +11.46% since 10/23/24 | +6.52% since 10/23/24 |
| Low | 3.18 on 11/22/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 51.81 on 10/28/24 | 86.08 on 11/19/24 |
| High | 4.14 on 10/10/23 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -9.84% since 06/16/23 | -16.61% since 07/23/24 | -10.32% since 07/23/24 | +37.60% since 07/23/24 | +30.56% since 07/23/24 |
| Low | 3.05 on 08/14/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 43.25 on 07/24/24 | 71.42 on 07/24/24 |
| High | 4.70 on 07/17/23 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,799 | 146,983,024 | 110,222,408 | 115,788,632 | 115,952,592 |
| Shares Outstanding, K | 9,398 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -57,560,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -4,530,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.11 | 0.56 | 0.40 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/14/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/23 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.620 on 01/03/25 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.30 | 0.00 | 48.75 | 20.98 |